SSRI CHINA news

2018

July: PatientsMap 2018 CN announces the top 15 companies with high sales rep visitation rates

 

Pfizer has the highest sales rep visitation rate in China followed by AstraZeneca and Bayer:

PatientsMap 2018 CN asks doctors about sales rep visitations of 69 pharmaceutical companies in the past month. Below table shows the top 15 pharmaceutical companies with the highest sales rep visitation rates. Top 7 companies are major global pharmaceutical companies, and Chinese local companies ranked 8th, 10th, 12th and 15th. No Japanese companies ranked within the top 15th, with the highest being Eisai at 21st (8.1%).

 

 

About PatientsMap

PatientsMap is a database product which uncovers the types of diseases that various specialists see, and the monthly patient volume for each disease. The data is collected from over 36,000 physicians (from Japan, USA, UK and China) covering approximately 400 diseases/conditions. PatientsMap data collection is conducted via online in collaboration with M3.

PatientsMap can also be used as a tool for estimating nationwide patient numbers for various diseases across, not only different specialties, but also by hospital size and regions. It can help you in analyzing the potential of a new drug and also for targeting the appropriate specialties in terms of market research and/or for promotional purposes.

PatientsMap China data is collected from over 10,000 physicians, covering approximately 350 diseases/conditions. (See details below)

Page Top